Home
 /
Papers
 /
Evolutionary Biology
 /
Regulatory variants drive Hsp90’s effect on adaptation
Preprint
Open access
V1
Top 1% · Validated by QED

Regulatory variants drive Hsp90’s effect on adaptation

Christopher M. Jakobson, José Aguilar-Rodríguez, Daniel F. Jarosz
February 2026
 ·
bioRxiv
 ·
DOI 
10.1101/2023.10.30.564848
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Evolutionary Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Overturning the protein-centric model of chaperone buffering, this paper shows Hsp90 primarily masks cis-regulatory rather than coding variation, transforming our understanding of how cryptic genetic diversity accumulates and is released to drive stress-dependent adaptation.

QED claims analysis

Summary

The stress-responsive chaperone Hsp90 controls the phenotypic consequences of genetic variation primarily through cis-regulatory variants rather than coding mutations, with most effects arising in genes encoding direct Hsp90/Hsp70 clients or targets of client kinases, where the chaperone modulates sigmoidal activity-fitness relationships to buffer variant effects under normal conditions and release cryptic phenotypic diversity under stress, with particularly strong effects on evolutionarily young genes that drive adaptive novelty.

See full analysis
Main Claim 1 –

Cis-Regulatory Variants Dominate Hsp90-Dependent Heredity Effects

Supporting evidence

  • Genome Editing Validates Causal Hsp90-Dependent Coding and Regulatory Variants
  • ERG11 Regulatory Variants Drive Hsp90-Buffered Antifungal Resistance
  • Hsp90 Alters Regulatory Variant Phenotypes Without Changing mRNA ASE
Main Claim 2 –

Hsp90-Dependent Mutations Enrich in Clients and Partner Targets

Supporting evidence

  • Hsp90 Reshapes Polygenic Traits via Coordinated Network-Connected Loci
  • Distinct ERG11 Variants Show Similar Hsp90-Buffered Phenotypes
  • CRISPRi ERG11 Knockdown Reveals Dose-Dependent Hsp90 Buffering
  • Haploinsufficient Genes Exhibit Stronger Hsp90-Dependent Buffering
Main Claim 3 –

Hsp90 Effects Are Strongest on Evolutionarily Young Genes

Abstract

The essential, stress-responsive protein chaperone Hsp90 impacts adaptation from microbes to humans. Yet the molecular mechanisms involved remain unclear and are often presumed to be driven by variation in opening reading frames. Here, we identify over 1,000 natural genotype-to-phenotype associations governed by Hsp90 at single-nucleotide resolution in Saccharomyces cerevisiae. Strikingly, cis-regulatory variants contributed to the chaperone’s effect on heredity more strongly than coding variation. Most of these mutations nonetheless impacted clients of Hsp90 or targets of its direct binding partners. The chaperone’s influence was especially potent on evolutionarily young genes, highlighting its influence on variation central to novelty. Synthetic reconstructions and genome editing revealed that Hsp90 may regulate the relationship between activity and phenotype for many dosage-sensitive genes. The unexpected role of the chaperone in buffering the effects of regulatory variants and releasing their consequences under stress suggests a mechanism for its widespread effects on evolution and development.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?